Supplementation with l-arginine stabilizes plasma arginine and nitric oxide metabolites, suppresses elevated liver enzymes and peroxidation in sickle cell anaemia
Authors:
- 1 June 2016
- journal article
- Published by Elsevier in Pathophysiology
- Vol. 23 (2) , 81-85
Abstract
No abstract availableKeywords
Funding Information
- University of Lagos, Lagos, Nigeria (2008/05)
This publication has 37 references indexed in Scilit:
- A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodesHaematologica, 2013
- Reference Intervals for Plasma L-Arginine and the L-Arginine:Asymmetric Dimethylarginine Ratio in the Framingham Offspring CohortThe Journal of Nutrition, 2011
- Biochemical Indicator of Sickle Cell Disease: Preliminary Report from IndiaIndian Journal of Clinical Biochemistry, 2011
- Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacityBlood, 2011
- Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain CrisisJAMA, 2011
- Pulmonary hypertension and NO in sickle cellBlood, 2010
- Hematologic, biochemical, and cardiopulmonary effects of l‐arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapyEuropean Journal of Haematology, 2009
- Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stressAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Protective effect of arginine on oxidative stress in transgenic sickle mouse modelsFree Radical Biology and Medicine, 2006
- Measurement of Nitric Oxide Production in Biological Systems by Using Griess Reaction AssaySensors, 2003